ATRA Abuzz, ATOS' COVID-19 Med Effective, INO And VXRT On Track

Today's Daily Dose brings you news about the near-term catalyst of Atara; promising lab study results of Atossa's COVID-19 med; the progress in Gilead/Galapagos' ulcerative colitis trial; the timeline of Inovio's COVID-19 vaccine and the progress in Vaxart's COVID-19 vaccine program.

from RTT - Biotech https://ift.tt/3cRAOG6
via IFTTT